BCL2 and ovarian carcinoma: In ovarian cancer, the expression of Bcl-2 was demonstrated to be epigenetically suppressed by HDAC1, which deacetylates histone H3K9,14 marks across Bcl-2 regulatory regions, resulting in reduced Bcl-2 transcription [120].